CCEL
Income statement / Annual
Last year (2025), Cryo-Cell International, Inc.'s total revenue was $31.57 M,
a decrease of 1.31% from the previous year.
In 2025, Cryo-Cell International, Inc.'s net income was -$2.43 M.
See Cryo-Cell International, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2025
|
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
| Period Ended |
11/30/2025 |
11/30/2024 |
11/30/2023 |
11/30/2022 |
11/30/2021 |
11/30/2020 |
11/30/2019 |
11/30/2018 |
11/30/2017 |
11/30/2016 |
| Operating Revenue |
$31.57 M |
$31.99 M |
$31.34 M |
$30.34 M |
$28.88 M |
$31.15 M |
$31.82 M |
$29.22 M |
$25.38 M |
$23.13 M |
| Cost of Revenue |
$7.38 M
|
$7.95 M
|
$8.44 M
|
$8.79 M
|
$8.99 M
|
$9.66 M
|
$10.04 M
|
$8.54 M
|
$6.72 M
|
$5.77 M
|
| Gross Profit |
$24.19 M
|
$24.04 M
|
$22.90 M
|
$21.54 M
|
$19.90 M
|
$21.49 M
|
$21.78 M
|
$20.68 M
|
$18.66 M
|
$17.35 M
|
| Gross Profit Ratio |
0.77
|
0.75
|
0.73
|
0.71
|
0.69
|
0.69
|
0.68
|
0.71
|
0.74
|
0.75
|
| Research and Development Expenses |
$376.26 K
|
$1.24 M
|
$1.17 M
|
$384.79 K
|
$49.87 K
|
$23.85 K
|
$30.15 K
|
$91.85 K
|
$41.17 K
|
$53.10 K
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$15.63 M
|
$13.48 M
|
$14.72 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General & Administrative Expenses |
$18.22 M
|
$18.52 M
|
$17.12 M
|
$15.58 M
|
$14.63 M
|
$14.29 M
|
$14.89 M
|
$15.63 M
|
$13.48 M
|
$14.72 M
|
| Other Expenses |
$751.47 K
|
$794.32 K
|
$16.92 M
|
$1.55 M
|
$1.22 M
|
-$489.53 K
|
$1.80 M
|
-$235.02 K
|
$131.61 K
|
$2.14 M
|
| Operating Expenses |
$19.35 M
|
$20.56 M
|
$35.21 M
|
$17.52 M
|
$15.88 M
|
$13.83 M
|
$16.72 M
|
$15.49 M
|
$13.65 M
|
$16.92 M
|
| Cost And Expenses |
$26.73 M
|
$28.51 M
|
$43.65 M
|
$26.31 M
|
$24.87 M
|
$23.49 M
|
$26.75 M
|
$24.03 M
|
$20.38 M
|
$22.69 M
|
| Interest Income |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Interest Expense |
$2.07 M
|
$1.86 M
|
$1.24 M
|
$1.52 M
|
$1.38 M
|
$1.54 M
|
$1.70 M
|
$1.55 M
|
$1.30 M
|
$947.34 K
|
| Depreciation & Amortization |
$1.37 M
|
$483.52 K
|
$1.71 M
|
$1.81 M
|
$1.33 M
|
$635.98 K
|
$401.31 K
|
$317.33 K
|
$230.00 K
|
$286.65 K
|
| EBITDA |
$1.10 M |
$1.42 M |
-$10.42 M |
$6.65 M |
$5.32 M |
$7.22 M |
$5.50 M |
$5.48 M |
$5.16 M |
-$1.25 M |
| EBITDA Ratio |
0.03
|
0.04
|
-0.33
|
0.22
|
0.18
|
0.23
|
0.17
|
0.19
|
0.2
|
-0.05
|
| Operating Income Ratio |
0.15
|
0.11
|
-0.39
|
0.13
|
0.14
|
0.25
|
0.16
|
0.18
|
0.2
|
0.02
|
| Total Other Income/Expenses Net |
-$7.18 M
|
-$676.16 K
|
-$1.06 M
|
-$705.52 K
|
-$1.41 M
|
-$2.62 M
|
-$1.67 M
|
-$1.57 M
|
-$1.38 M
|
-$2.91 M
|
| Income Before Tax |
-$2.34 M
|
$2.80 M
|
-$13.36 M
|
$3.32 M
|
$2.61 M
|
$5.04 M
|
$3.39 M
|
$3.62 M
|
$3.62 M
|
-$2.48 M
|
| Income Before Tax Ratio |
-0.07
|
0.09
|
-0.43
|
0.11
|
0.09
|
0.16
|
0.11
|
0.12
|
0.14
|
-0.11
|
| Income Tax Expense |
$92.23 K
|
$2.40 M
|
-$3.84 M
|
$547.54 K
|
$527.71 K
|
$1.41 M
|
$1.10 M
|
$4.47 M
|
$1.31 M
|
-$1.16 M
|
| Net Income |
-$2.43 M
|
$402.10 K
|
-$9.52 M
|
$2.77 M
|
$2.08 M
|
$3.62 M
|
$2.29 M
|
-$854.82 K
|
$2.32 M
|
-$1.32 M
|
| Net Income Ratio |
-0.08
|
0.01
|
-0.3
|
0.09
|
0.07
|
0.12
|
0.07
|
-0.03
|
0.09
|
-0.06
|
| EPS |
-0.3 |
0.05 |
-1.14 |
0.33 |
0.26 |
0.48 |
0.29 |
-0.11 |
0.33 |
-0.16 |
| EPS Diluted |
-0.3 |
0.05 |
-1.14 |
0.33 |
0.25 |
0.45 |
0.27 |
-0.11 |
0.3 |
-0.16 |
| Weighted Average Shares Out |
$8.07 M
|
$8.13 M
|
$8.34 M
|
$8.47 M
|
$8.14 M
|
$8.14 M
|
$8.41 M
|
$7.46 M
|
$7.06 M
|
$8.11 M
|
| Weighted Average Shares Out Diluted |
$8.07 M
|
$8.21 M
|
$8.34 M
|
$8.48 M
|
$8.36 M
|
$8.14 M
|
$8.41 M
|
$7.46 M
|
$7.65 M
|
$8.11 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
